DEVICE Act of 2023

The DEVICE Act of 2023, also known as Bill 118 hr 1090, is a piece of legislation currently being considered by the US Congress. The main purpose of this bill is to streamline the process for approving medical devices in order to ensure that patients have timely access to innovative and safe technologies.

One of the key provisions of the DEVICE Act is the establishment of a new regulatory pathway for certain medical devices that are considered low to moderate risk. This pathway would allow these devices to be approved based on a streamlined review process, which would help to reduce the time and cost associated with bringing new technologies to market.

Additionally, the bill includes measures to improve the transparency and efficiency of the medical device approval process. This includes requiring the Food and Drug Administration (FDA) to provide more detailed information about the status of device applications and to make this information publicly available. The DEVICE Act also aims to enhance collaboration between the FDA and industry stakeholders by establishing a new advisory committee to provide input on regulatory issues related to medical devices. This committee would be made up of experts from a variety of fields, including medicine, engineering, and patient advocacy. Overall, the DEVICE Act of 2023 seeks to modernize and improve the regulatory framework for medical devices in the United States. By streamlining the approval process and increasing transparency and collaboration, this bill aims to ensure that patients have access to the latest and safest medical technologies.